| Trends in perinatal transmission of HIV/AIDS in the United States. | |
| | |
MedLine Citation:
|
PMID: 10450714 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
CONTEXT: Since 1994, the US Public Health Service (PHS) has recommended routine, voluntary prenatal human immunodeficiency virus (HIV) testing and zidovudine therapy to reduce perinatal HIV transmission. OBJECTIVE: To describe trends in incidence of perinatal AIDS and factors contributing to these trends, particularly the effect of PHS perinatal HIV recommendations. DESIGN, SETTING, AND PARTICIPANTS: Analysis of nationwide AIDS surveillance data and data from HIV-reporting states through June 1998. MAIN OUTCOME MEASURES: Trends in AIDS by year of diagnosis, incidence rates of AIDS and Pneumocystis carinii pneumonia (PCP) among infants younger than 1 year from US natality data for birth cohorts 1988 to 1996; expected number of infants with AIDS from national serosurvey data; and zidovudine use data from selected HIV-reporting states. RESULTS: Perinatal AIDS cases peaked in 1992 and then declined 67% from 1992 through 1997, including an 80% decline in infants and a 66% decline in children aged 1 to 5 years. Rates of AIDS among infants (per 100000 births) declined 69%, from 8.9 in 1992 to 2.8 in 1996 compared with a 17% decline in births to HIV-infected women from 1992 (n = 6990) to 1995 (n = 5797). Among infants, PCP rates per 100000 declined 67% (from 4.5 in 1992 to 1.5 in 1996), similar to the decline in other AIDS conditions. The percentage of perinatally exposed children born from 1993 through 1997 whose mothers were tested for HIV before giving birth increased from 70% to 94%; the percentage who received zidovudine increased from 7% to 91%. CONCLUSIONS: According to these data, substantial declines in AIDS incidence were temporally associated with an increase in zidovudine use to reduce perinatal HIV transmission, demonstrating substantial success in implementing PHS guidelines. Reductions in the numbers of births and effects of therapy in delaying AIDS do not explain the decline. |
| | |
Authors:
|
M L Lindegren; R H Byers; P Thomas; S F Davis; B Caldwell; M Rogers; M Gwinn; J W Ward; P L Fleming |
Related Documents
:
|
1492934 - Estimating the incubation period of paediatric aids in rwanda. 8383734 - Use of bayes theorem to estimate the impact of the proposed cd4-based expansion of the ... 19880284 - A comparison of ad hoc methods to account for non-cancer aids and deaths as competing r... 1671424 - Serial cd4 lymphocyte counts and development of aids. 21367544 - A systematic review of menopausal symptom management decision aid trials. 10172684 - Correlates of functioning in a population with dual diagnoses: an examination of diagno... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: JAMA : the journal of the American Medical Association Volume: 282 ISSN: 0098-7484 ISO Abbreviation: JAMA Publication Date: 1999 Aug |
Date Detail:
|
Created Date: 1999-08-19 Completed Date: 1999-08-19 Revised Date: 2008-11-21 |
Medline Journal Info:
|
Nlm Unique ID: 7501160 Medline TA: JAMA Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 531-8 Citation Subset: AIM; IM; X |
Affiliation:
|
Division of HIV/AIDS Prevention: Surveillance and Epidemiology, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. mll3@cdc.gov |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
AIDS-Related Opportunistic Infections
/
epidemiology Anti-HIV Agents / therapeutic use Child Child, Preschool Female HIV Infections / drug therapy, epidemiology*, prevention & control, transmission* Humans Incidence Infant Infant, Newborn Infectious Disease Transmission, Vertical / prevention & control, statistics & numerical data* Male Pneumonia, Pneumocystis / epidemiology Population Surveillance Pregnancy Pregnancy Complications, Infectious / drug therapy United States / epidemiology Zidovudine / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Anti-HIV Agents; 30516-87-1/Zidovudine |
| Comments/Corrections | |
Comment In:
|
JAMA. 1999 Aug 11;282(6):577-9
[PMID:
10450721
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Enhancement of tumor-to-nontumor localization ratios by hepatocyte-directed blood clearance of antib...
Next Document: Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients wit...